ICON experts frequently author or contribute to industry trade press. The following are some recent articles.
ICON Oncology’s Opinion of How We Can Reach for the Stars With a Moonshot
ICON experts contribute to this article in Clinical Oncologist Daily on ICON's decision to invest in a Cancer Moonshot project using quantum computing.
APAC is the fastest growing market for CRO industry
clinical trials in the APAC region.
Transforming Trials: Reducing Cost and Risk
An article by Dr. Phil Birch on some strategies for transforming clinical trials.
Effective Sponsor-CRO Collaboration
Commentary in PharmaVOICE on effective sponsor-CRO collaboration.
ICON Recognised for Excellence in Vaccine Development
Article on the future of drug development and the central role that precision medicine will play in global healthcare.
Predatory Journals Are Back in the Firing Line
Learn how to spot a predatory journal with these tips from PubsHub.
Overcoming Four Challenges to Successful Rare Disease Drug Development
Article relating to overcoming challenges to greatly improve the chances for a successful rare or “orphan” drug trial.
Why a Patient's Experience with a Drug Matters
Patient reported outcomes are often the primary endpoints in FDA approved pain drugs.
PRO Instruments to Improve Endpoints for Antibacterial Drug Trials
FDA's selection of ICON to validate PRO instruments used to access clinical endpoints in antibacterial drug trials.
Cell and Gene Therapies: On Course for Commercial Success?
Article on cell and gene therapies